Uncategorized
VIDEO: Luminate meets primary endpoint in phase 2 study for vitreomacular traction
SEATTLE — At the Association for Research in Vision and Ophthalmology meeting, Baruch D. Kuppermann, MD, discusses results of the phase 2 study of Allegro’s Luminate for the treatment of vitreomacular traction.